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Background: Neuropsychological alterations can lead to inaccurate perception,
interpretation, and response to environmental information, which could be a risk factor
for suicide.
Methods: Ninety-six subjects were recruited from the Psychiatry Department of the
Araba University Hospital—Santiago, including 20 patients with a recent attempt and
diagnosis of major depressive disorder (MDD) according to DSM-V, 33 MDD patients with
history of attempted suicide, 23 non-attempter MDD patients, and 20 healthy controls.
All participants underwent a clinical interview and neuropsychological assessment on
the following cognitive domains: working memory, processing speed, decision-making,
executive function, and attention. Backward multiple regressions were performed
adjusting for significant confounding variables. For group comparisons, ANOVA and
Bonferroni post-hoc tests were performed with a p < 0.05 significance level.
Results: The patient groups did not differ regarding severity of depression and stressful
events in the last 6 months. In comparison to healthy controls, depressed patients
with lifetime suicide attempts had more general trauma (p = 0.003), emotional abuse
(p = 0.003), emotional negligence (p = 0.006), and physical negligence (p = 0.009),
and depressed patients with recent suicide attempts had experienced more child
sexual abuse (p = 0.038). Regarding neuropsychological assessment, all patient
groups performed significantly worse than did healthy controls in processing speed,
decision-making, and attention. Comparisons between patient groups indicated that
recent suicide attempters had poorer performance on executive function in comparison
to both depressed lifetime attempters and depressed non-attempters (B = 0.296,
p = 0.019, and B = 0.301, p = 0.028, respectively). Besides, women with recent
attempts had slightly better scores on executive function than males. Regarding the rest
of the cognitive domains, there were no significant differences between groups.
Conclusion: Executive function performance is altered in recent suicide attempts. As
impaired executive function can be risk factor for suicide, preventive interventions on
suicide should focus on its assessment and rehabilitation.
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INTRODUCTION
Suicide is a major health issue worldwide involving nearly
800,000 deaths per year (1). Identifying risk factors can lead
to a better understanding and prevention of this behavior (2).
Age, sex, history of previous attempts, genetic predisposition,
drug consumption, and early adversity, among others, have been
extensively reported as relevant features that can predict a suicide
attempt (3–6).
Additionally, neuropsychological performance has been
linked to suicide in several studies across all the life span.
Impaired complex cognition, social cognition, and episodic
memory (7, 8) were reported in adolescents at risk of
suicide. In children with a family history of suicide attempts,
cognitive, attention, and language reasoning have been described,
increasing their risk of reproducing a suicide attempt themselves
(9). In contrast, McHugh et al. (10) found better cognitive
functioning on processing speed, verbal learning, working
memory, delayed memory, and verbal fluency in suicidal
youngsters and young adults.
In adult and elderly populations, many studies have provided
evidence of alterations in executive function (11–13), attention
(14), memory (15), and decision-making (13, 16, 17) in
suicide attempters. Deficits in these cognitive domains, especially
executive function that organizes and directs behavior, can lead to
an inaccurate perception, interpretation, retrieval, and response
to environmental information, which may result in an inflexible,
pessimistic way of thinking about their future and themselves
(18). Thus, these cognitive deficits may imply a higher risk of
suicide as a response to adverse life events. In summary, existing
evidence supports a connection between cognition and suicide.
However, these studies do not determine the specific cognitive
alterations involved in a recent suicide attempt, that is, the
current altered processes that surround and may contribute to
suicidal behavior. Besides, these cognitive alterations are not
unique to suicide and have also been described in depressive
patients (19–24); therefore, it remains unclear which specific
cognitive domains are altered in recent suicidal behavior.
Considering data scarcity, the aim of this study was to explore
cognitive alterations in recent suicide attempts. For this purpose,
we compared the neuropsychological performance of depressed
patients with a recent attempt, depressed patients with a history
of suicide, depressed non-attempters, and healthy controls on
the following cognitive domains: working memory, processing
speed, decision-making, executive function, and attention.
MATERIALS AND METHODS
Participants
Ninety-six participants were recruited from the Psychiatry
Department of the Araba University Hospital—Santiago. All
patients were diagnosed of major depressive disorder (MDD)
according to the Diagnostic and Statistical Manual of Mental
Disorders, 5th edition (DSM-5) criteria and were receiving
psychopharmacological treatment for their condition. The
sample was categorized into the following groups: 20 depressed
patients who were hospitalized after a recent suicide attempt
(≤30 days), 33 patients with a past suicide attempt during their
lifetime and hospitalized for MDD episodes, 23 without history
of suicidal attempts and hospitalized for MDD episodes, and 20
healthy controls with no personal or family history of mental
illness matched by age and sex with a reference group, that is,
a recent suicide attempt group. Suicide attempt was defined as
a “self-initiated sequence of behaviors by an individual who, at
the time of the initiation, expected that the set of actions would
lead to his or her own death” (DSM-5). The exclusion criteria for
the three groups including patients were: presence of psychotic
symptoms and other comorbid psychiatric disorders with the
exception of tobacco use disorder, acute infections, neurological
illness, intellectual disability, dementia, organic diseases that
compromise cognitive functioning, and cognitive syndromes.
In addition to this, the exclusion criteria for healthy controls
included either personal or a family history of major psychiatric
disorders. All participants were between 18 and 65 years old
and had signed an informed consent. This study was approved
by the ethical board of the Araba University Hospital and was
conducted according to the Declaration of Helsinki (25).
Procedure and Measures
After recruitment and signature of the informed consent,
each participant had an interview with a psychologist for
sociodemographic data collection and clinical assessment of
depressive symptoms, stressful events, and childhood trauma.
Depressive symptom severity was assessed using the 17-item
Spanish version of the Hamilton Depression Rating Scale
(HDRS) (26, 27), a structured instrument widely used in the
psychiatric field (28–30) that offers a quantitative measure of
the severity of depressive symptoms in a clinical population
according to the criteria of the evaluator who conducts the
clinical interview. Each item has between three and five possible
responses with 0–2 or 0–4 scores, respectively, and the total
score ranges from 0 to 52. The 17-item Spanish version has
good reliability, with a Cronbach’s α of 0.72, and validity
with a correlation with other scales for depressive symptoms
(Montgomery–Asberg and Beck’s Depression Inventory) ranging
from 0.8 to 0.9. Recent (6 months) stressful events were measured
TABLE 1 | Cognitive domains.
Working
memory
WAIS-IV Arithmetic: total score




WAIS-IV Symbol Search: total score




Iowa gambling test: total money score Bechara et al. (46)
Executive
function
Wisconsin sorting card test: categories, errors,
perseverative errors Heaton (47)
Stroop test: interference score Golden (48)
FAS test: total correct answers Buriel et al. (49)
Attention Stroop test: color word Golden (48)
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using the Spanish version of the List of Threatening Experiences
(LTE) (31, 32), a 12-item brief questionnaire with yes/no
responses regarding personal, relational, financial, and health
problems. This questionnaire has a high test–retest reliability
(κ = 0.61–0.87) and is a valid and reliable measure of stressful
events in mental health, specifically in depression (OR = 1.64–
2.57) (32), which has been previously used in studies with
psychiatric populations (33–36). Childhood abuse and neglect
were assessed with the Spanish version of the Childhood Trauma
Questionnaire—Short Form (CTQ-SF) (37), a self-administered
28-item questionnaire with five Likert responses (never, rarely,
sometimes, often, and always) that has been extensively used (38–
43) to evaluate the maltreatment dimensions that were detected
in the original factorial analysis for construct validity (44):
emotional (Cronbach’s α = 0.87), physical (Cronbach’s α = 0.89)
and sexual abuse (Cronbach’s α = 0.94) and physical (Cronbach’s
α = 0.66) and emotional (Cronbach’s α = 0.83) neglect (37).
Besides, the participants underwent a neuropsychological
assessment using a standardized test on the following cognitive
domains: working memory, processing speed, decision-making,
executive function, and attention. The test and measures used
in each domain (Table 1) were adapted from previous existing
literature on cognitive assessment in mental disorders (50, 51).
Statistical Analyses
Statistical analysis was performed by an expert biomedical
statistician. Data were checked for Gaussian distribution.
Comparisons between groups regarding the sociodemographic
and clinical variables were performed with ANOVA followed
by Bonferroni post-hoc testing for continuous variables and chi-
square for categorical variables. For the analyses of cognitive
performance, measures selected from each test (Table 1) were
gathered into the corresponding cognitive domain that is
evaluated and the obtained scores were transformed to average z-
scores. Backward multiple regressions were performed adjusting
for the following confounding variables: age, sex, economic
status, education, marital status, drug consumption (tobacco,
cannabis, and alcohol), and severity of depressive symptoms
according to the HDRS. In each model, only significant
confounders were taken into account.
RESULTS
Sociodemographic and Clinical Variables
There were no significant differences between groups regarding
sociodemographic variables (Table 2). In the recent attempt
group, 35% of patients were recruited after an index attempt,
40% of patients reattempted for the second time, and 60% of
patients had more than two reattempts. In the lifetime attempt
group, 6.3% of patients had attempted suicide once, 34.4% twice,
and 59.3% more than twice. Regarding psychiatric medication,
the majority had similar treatments as 94% were under
polytherapy consisting of antidepressants and benzodiazepines,
















Sex, n (%) Female 13 (65%) 26 (78.8%) 18 (78.3%) 14 (70%) X2 = 1.617; p = 0.656
Male 7 (35%) 7 (21.2%) 5 (21.7%) 6 (30%)
Age, mean (SD) 44.70 (8.785) 44.45 (12.765) 50.57 (9.926) 44.58 (9.221) F (3,91) = 1.842; p = 0.145
Education level, n (%) Primary 2 (10%) 6 (18.2%) 5 (21.7%) 0 (0%) X2 = 9.886; p = 0.360
Secondary 7 (35%) 11 (33.3%) 7 (30.4%) 6 (30%)
Preparatory 5 (25%) 9 (27.3%) 6 (26.1%) 4 (20%)
University 6 (30%) 7 (21.2%) 5 (21.7%) 10 (50%)
Economic status, n (%) Low 7 (38.9%) 10 (37%) 10 (50%) 6 (33.3%) X2 = 5.611; p = 0.468
Medium 9 (50%) 11 (40.7%) 10 (50%) 9 (50%)
High 2 (11.1%) 6 (22.3%) 0 3 (16.7%)
Previous suicide attempts, mean (SD) 1.47 (1.87) 2.34 (2.04) – – t = −1.52; p = 0.1
Age of index attempt, mean (SD) 33.55 (11.91) 31.83 (15.35) – – t = 0.42; p = 0.67
Previous depressive episodes, mean (SD) 2.60 (2.90) 7.50 (9.81) 2.38 (1.59) – F (2,47) = 2.16; p > 0.05
Depression severity (HDRS), mean (SD) 15.50 (7.23) 17.87 (6.54) 14.36 (8.93) 1.60 (2.09) F (3,89) = 25.741; p < 0.01
Stressful events (LTE), mean (SD) 2.80 (1.70) 2.53 (2.11) 2.56 (1.90) 0.5 (1.15) F (3,91) = 7,281; p < 0.01
CTQ total, mean (SD) 57 (25.63) 64.1 (21.66) 52.57 (23.06) 38.15 (7.12) F (3,80) = 4.54; p < 0.05
CTQ emotional abuse, mean (SD) 11.15 (6.63) 13.19 (6.16) 10.38 (6.08) 7.57 (2.90) F (3,82) = 3.112; p < 0.05
CTQ physical abuse, mean (SD) 8.80 (4.93) 8.13 (5.02) 8.10 (5.73) 6.21 (2.36) F (3,82) = 0.813; p = 0.49
CTQ sexual abuse, mean (SD) 10 (7.48) 8.81 (5.58) 6.14 (2.15) 5.07 (0.27) F (3,82) = 3.789; p < 0.05
CTQ emotional negligence, mean (SD) 10.2 (5.02) 14.13 (6.07) 10.67 (5.94) 8.08 (1.85) F (3,80) = 4.736; p < 0.05
CTQ physical negligence, mean (SD) 11.55 (2.58) 13.06 (3.18) 11.68 (3.48) 9.93 (1.90) F (3,83) = 3.770; p < 0.05
HDRS, Hamilton Depression Rating Scale; LTE, List of Threatening Experiences; CTQ, Childhood Trauma Questionnaire.
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whereas 6% of patients were under monotherapy of either of
those treatments.
In addition to having similar medication profiles, the severity
of depressive symptoms was equally distributed across groups.
Bonferroni post-hoc analyses revealed that all groups had
significantly higher scores for depressive symptoms measured
by the HDRS than did the healthy controls (p < 0.01 in each
comparison), but the severity of depression was similar across
patient groups. Besides, healthy controls had fewer stressful
events in the last 6 months than each of the patient groups (p
< 0.05 in each comparison).
Also, post-hoc analyses of the CTQ-SF scores indicate greater
general trauma (p = 0.003), emotional abuse (p = 0.003),
emotional negligence (p = 0.006), and physical negligence (p
= 0.009) in patients with a history of suicide attempts in
comparison to healthy controls. Besides, patients with recent
suicide attempts reported higher scores of child sexual abuse
(p= 0.038) than did healthy controls.
Performance on Cognition
The scores on the five domains included in this study are
presented in Table 3.
Backward stepwise multiple regressions were performed
and adjusted by significant confounders (age, sex, economic
level, marital status, years of education, severity of depression,
and substance consumption) with healthy controls as the
reference group. Healthy controls performed significantly better
in processing speed, decision-making, and attention than did
all groups of depressed patients, with no differences between
them (Table 4).
As the main objective of this study was to determine
the cognitive differences between recent suicide attempters
and current non-suicidal depressed patients, the reference
group for adjusted regressions was afterwards changed to
recent attempters. The results yielded significant differences on
the executive function domain. Both lifetime attempters and
depressed non-attempters had significantly higher scores in
this domain in comparison to recent attempters (B = 0.296,
p = 0.019, and B = 0.301, p = 0.028, respectively); that is,
recent suicide attempters had poorer performance on executive
function. However, there were no significant differences between
groups in the rest of the cognitive domains.
Further analyses showed that there was an interaction
between group (depressed recent attempters, depressed lifetime
attempters, and depressed non-attempters) and sex on executive
performance (Table 5). According to these results, women with
recent attempts had slightly better scores on executive function
than did males. However, in the rest of the groups, men
outperformed women, especially in depressed non-attempter
patients, with a large effect size indicating a strong interaction
between sex and group.
DISCUSSION
The main finding of this study is that MDD patients with
suicide attempts in the last 30 days have significantly poorer
performance on executive function compared to MDD patients
with a previous history of suicide attempts and to MDD non-
attempter patients. This finding indicates that suicide might
be accompanied with an altered performance on executive
function. Deficits in this cognitive domain have already been
described in patients with a history of suicidality (12, 14, 52–
56) and in depressed patients without suicidal behavior (23,
53), especially in those with poor treatment response (57),
but to the best of our knowledge, this is the first study that
compares MDD patients with recent attempts, MDD patients









Working memory −0.577 (0.822) −0.825 (0.867) −0.798 (0.845) 0 (0.784)
Processing speed −1.002 (0.821) −1.403 (1.444) −1.306 (1.411) 0 (0.944)
Decision making −0.772 (1.089) −0.726 (1.053) −0.873 (0.889) 0 (1.000)
Executive function −0.191 (0.256) 0.066 (0.484) 0.070 (0.530) 0.021 (0.313)
Attention −0.910 (0.770) −1.025 (0.667) −0.913 (0.646) 0.046 (0.781)
aData are presented as means and standard deviations. All values are z-scores.






Recent attempters −0.113 −1.065* −0.829* −0.229 −0.604*
Lifetime
attempters
−0.221 −1.416** −0.664* 0.068 −0.577*
Depressed
non-attempters
−0.313 −1.050* −0.782* 0.072 −0.567*
*p < 0.05; **p < 0.001. aData are presented as adjusted B coefficients assuming “healthy controls” as the reference group.
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TABLE 5 | Effect sizes of being female on executive functiona.
Femaleb
Recent attempters 0.088 (−0.301, 0.478)
Lifetime attempters −0.239 (−0.624, 0.146)
Depressed non-attempters −0.663 (−1.134, −0.192)
Healthy controls −0.189 (−2.058, 1.680)
aAdjusted for potential confounders.
bEffect size is interpreted as the difference in average executive function domain between
females and males.
with lifetime attempts, MDD non-attempter patients, and
healthy controls.
Executive function directs thought and behavior toward an
objective in order to respond to current or future situational
demands. According to the comprehensive model proposed by
Miyake et al. (58), this implies the inhibition of responses,
shifting between tasks and the constant update of the working
memory. Other authors also include planning, decision-making,
working memory, and error detection among its functions
(59, 60). All in all, these processes allow the deliberate and
intentional goal-directed response to environmental stimuli
and are subject to the influence of individual factors, such
as emotional regulation, personality traits, and even traumatic
events (61–63). Deficits in these processes can lead to the
dysregulation of emotion, thoughts, and actions (64), which
might contribute to considering suicide as a solution under
critical circumstances (15). In addition, these alterations may
also increase interpersonal difficulties, increasing the risk of
attempted suicide (17).
According to our results, sex has an influence on executive
function. The slightly better performance of women in the recent
attempt group may be possibly explained by the fact that higher
impulsivity scores have been related to men (61), which implies a
tendency to think and behave with less planning, error detection,
cognitive flexibility, and inhibitory control (65), processes that
are under control of the executive function. Therefore, men are
more likely to make non-adaptive choices under demanding or
stressing circumstances as risky behavior or suicide. However,
depressed non-attempter men had significantly better executive
function performance. This may be due to the fact that women
have more severe cognitive symptoms of depression, such as
rumination and hypochondria (66), and a greater impact on
their functionality (67). Apart from psychological factors, there
are also biological differences, such as sex hormones (68, 69),
dysregulation of the hypothalamus–pituitary–adrenal (HPA) axis
(70), and inflammatory parameters (71), that make depression
more adverse for women.
Additionally, the neuropsychological assessment results
revealed that all depressed patients with similar depression
severity performed significantly worse than did healthy controls
in processing speed, decision-making, and attention, but with
no difference between groups. This suggests that depressed
patients have alterations in these specific dimensions associated
with their psychopathological process; that is, major depressive
disorder is consistent with previous literature (21, 54, 72, 73).
According to our findings, these alterations are different from
those associated specifically with recent suicide attempts and,
therefore, different cognitive processes are specifically more
altered in each condition.
Apart from the neurocognitive deficits, traumatic life events
are also associated with a higher risk of suicide. Patients with
a history of childhood maltreatment (74–76) and sexual abuse
(77) have an increased risk of suicidal behavior in their adult
life. In our sample, patients with recent suicide attempts reported
more child sexual abuse than the rest of the groups. Patients with
a history of suicide reported more general trauma, emotional
abuse, and negligence, and in general, patients had more recent
stressful events than did the controls. Furthermore, the link
between trauma, executive function alterations, and suicidal
behavior has also been described by several authors. In a recent
study by Zelazny et al. (76), higher scores on executive function
were protective against suicide in individuals with childhood
maltreatment. Carvalho et al. (78) found that maltreated children
performed worse than did non-maltreated children in executive
function tests, and according to the study by Dannehl et al.
(79), these differences are also present in adults with a history
of childhood adversity, especially in those with physical abuse
and neglect.
In conclusion, recent suicidal behavior is specifically
associated with deficits on executive function, which suggests a
cognitive dysfunction on information processing and response,
especially in critical events. As executive function can be trained
and improved (80), cognitive screening and stimulation may be
proposed as a strategy for suicide prevention in at-risk patients.
Future studies are needed to identify possible differences between
sex in each cognitive domain for a more personalized approach
and for a better understanding of early detection vulnerability
factors that may enable us to prevent suicide in at-risk patients.
Limitations
This study has a number of limitations. Recent and past trauma
events were assessed using self-administered and self-reported
scales in MDD patients who can be biased when reporting this
information. As more women have recently attempted suicide
than men, the sex-related differences on executive function
found in recent attempters must be interpreted with caution,
and further confirmatory studies are advisable. Moreover, some
factors that have been described in the literature as potentially
influencing suicidal behavior inmajor depression, such as anxiety
(81) or mixed symptoms (82), were not assessed.
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